Looking to sell Cockroach Labs stock or options?
Cockroach Labs has developed an open-source database platform that aids in the creation of scalable, global cloud services capable of surviving disasters. The company's unique cloud-native SQL database merges the functionality of SQL with the horizontal scalability commonly found in NoSQL offerings. It also offers enterprise-grade disaster recovery. This allows developers to quickly iterate without compromising consistency, and to concentrate on crucial tasks, rather than fixing database deficiencies.
Lone Pine Capital, BOND Capital (San Francisco), JP Morgan Chase, Sequoia Capital, FirstMark Capital, G Squared, Palm Drive Capital, Greenoaks Capital Partners, Redpoint Ventures, Benchmark Capital Holdings, MicroVentures, Index Ventures, In-Q-Tel, GV, Work-Bench, Tiger Capital Partners, Tiger Global Management, Altimeter Capital Management, K5 Global, SV Angel, Toba Capital, Firebolt Ventures, Coatue Management.
Cockroach Labs is currently a private company. This means that the company is not listed on any public exchange and so there is no public market for its stock. However, there may still be ways to monetize Cockroach Labs stock. Depending on Cockroach Labs’s policies, you may be able to: (1) find a private buyer in the secondary market to purchase your stock, (2) borrow against your stock, or (3) exchange Cockroach Labs stock into the Collective Exchange Fund for a limited partnership interest and then borrow non-recourse against your interest to generate immediate cash. This last alternative can be much quicker and net you more after-tax cash than your other options. An exchange into our fund also reduces your risk by diversifying your holdings out of an over-concentrated position.
Collective Liquidity can provide liquidity to shareholders of Cockroach Labs stock in two ways. First, Cockroach Labs employees can exchange shares into the Collective Exchange Fund and then borrow non-recourse to generate immediate cash. This can net you more after-tax cash than a stock sale. It also reduces your risk by diversifying your holdings out of an over-concentrated position. In some cases, Collective may also be able to purchase your Cockroach Labs stock. Note that all transactions in Cockroach Labs shares are subject to the company’s policies regarding secondary transactions. Schedule a call with a Collective Liquidity representative to learn more about your private market liquidity alternatives.
Cockroach Labs stock is not listed on any public exchange and so there is no public market for its shares. Therefore, there is no single, centralized price for Cockroach Labs stock. Typically, shares of private companies like Cockroach Labs are set with buyers in one off negotiations. Collective Liquidity, however, uses a proprietary algorithm to determine its bids so we almost always have an immediately actionable price for you.
On Dec 2021, Cockroach Labs is reported to have closed an equity financing in which the investors valued the company at $5.0B. This valuation is typically calculated by multiplying the per share price of the preferred stock sold in the financing by the number of Cockroach Labs shares outstanding assuming the conversion of all stock options, warrants, etc.
Tickers are used to identify company’s shares on public markets like the NYSE or Nasdaq. Because Cockroach Labs is not currently publicly traded, it does not have a ticker symbol.
Cockroach Labs has not yet conducted an initial public offering (“IPO”) and so remains a private company. Though Cockroach Labs is a well-known, successful company, there can be no assurance that it will ever go public or be sold. Because of the risk this imposes on Cockroach Labs shareholders, many investors elect to gain liquidity for at least some of their shares before the IPO. Schedule a call with a Collective Liquidity representative to discuss your private market liquidity alternatives.